CLINICAL_TRIALS
trial_result
· 2020-11-16
Clinical Trial Update: POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma [Phase 2]
Summary
Phase 2 trial comparing POLAT-001 to latanoprost in ocular hypertension and open-angle glaucoma has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peregrine Ophthalmic | Conditions: Glaucoma | Phase 2 | Status: COMPLETED | Results posted: 2020-11-16